"The fund is expected to deliver a balanced risk-adjusted return." This is how the report by Scope analysts for the rating of the Dr. Peters-Hotelfonds DS 142, published this Wednesday, begins. The Scope experts are particularly positive about the lease that will run beyond the fund's term and the opening of the new hotel building in Oberpfaffenhofen.
Other independent analysts - such as those of the financial analysis company TKL - are similarly favourable. Their plausibility check confirms that Dr. Peters Group's current hotel fund has below-average costs, below-average risk and a clear competitive advantage over other local hotels thanks to the renowned Courtyard by Marriott brand.
It’s not just the fund parameters that are convincing: the information service investmentcheck.de recently indorsed the fund sales materials as being of excellent quality. The willingness to provide information and the communication transparency regarding the current product were also rated positively. As a result, Dr. Peters Group received four and a half out of five stars. Not least due to the comprehensible forecast in the prospectus of the real estate investment "DS 142 Hotel Oberpfaffenhofen".